A message to our global staff, partners, and supporters:
As COVID-19 continues to impact the world, we are committed to doing our part to slow the spread of illness while keeping our communities—especially treatment providers and children in treatment—safe and healthy.
MiracleFeet, like many organizations, has moved to a remote-work environment and has stopped all travel. We are actively working with our local partners and teams to mitigate the spread of the virus, while continuing to support children and their families enrolled in treatment at 240+ clinics worldwide. While many countries where we work are not yet dealing with high numbers of coronavirus cases, we are preemptively working with our local teams to limit the risks associated with visiting public hospitals. These measures include prioritizing children who are in the middle of treatment while tracking and triaging new cases for future treatment.
The world continues to turn despite the virus. Babies are still being born, children continue to grow, and the need for clubfoot treatment doesn’t grind to a halt. Right now, we are putting families’ safety first, ensuring patients’ short-term needs are met, and that families are included in decision-making and informed of options and changes in treatment protocols.
Although there is much uncertainty as the situation evolves, we take solace in the fact that we have an incredibly dedicated staff and partners, and a compassionate and loyal community of supporters. In this challenging and uncertain time, our strength comes from caring for each other. The safety and well-being of the children we serve will always be at the heart of every decision we make.
Take care and be well.
The MiracleFeet Team
Treating clubfoot is one of the most effective investments in public health today.
MiracleFeet offers an incredible return on investment: $500—the average cost of complete treatment in the countries where we work—changes a child’s life and generates an average of $120,000 of additional income in lifetime earnings, a social return of 240 times the initial investment.